Nasdaq:US$17.48 (+0.04) | HKEX:HK$27.68 (+0.08) | AIM:£2.54 (+0.07)
搜索结果
上一篇文章   |   下一篇文章
公告及新闻稿, 其他业务 | 2014-04-17

Chi-Med and Sinopharm complete regulatory approval for the establishment of new China drug distribution and marketing Joint Venture